K-numberK253564
Device nameuMI Panvivo (uMI Panvivo); uMI Panvivo (uMI Panvivo S); uMI Panvivo (uMI Panvivo EX); uMI Panvivo (uMI Panvivo ES)
ApplicantShanghai United Imaging Healthcare Co., Ltd.
Product codeKPS
Device classClass II
Decision dateFeb 13, 2026
DecisionSubstantially Equivalent
Regulation892.1200
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The uMI Panvivo is a combined PET/CT imaging system that provides anatomical and functional images for diagnostic and therapeutic purposes. It is intended for assessing metabolic and physiologic functions in various body areas, supporting clinical applications in oncology, cardiology, neurology, and other specialties, and can aid in radiotherapy planning and lung cancer screening.

Technological characteristics

The proposed devices feature scalable PET detector rings (100, 80, 180, or 240 rings) with corresponding axial fields of view (295, 235, 534, or 712 mm) compared to the predicate's 100 and 80 rings. Newer models (ES and EX) have longer coincidence timing windows (4.9 ns vs. 4.6 ns) to accommodate more lines of response, and improved sensitivity and NECR peak values. Advanced features include NeuroFocus.Brain, uExcel DPR deep learning reconstruction, and Intelligent Assistant, which are new to the longer-axial models.

Test standards cited

Conformance claimed to ANSI/AAMI ES60601-1, IEC 60601-1-2 and 60601-1-3, IEC 60601-2-44, NEMA NU 2-2018, IEC 62304 (software lifecycle), ISO 10993 (biocompatibility), ISO 14971 (risk management), and 21 CFR Part 820 (Quality System Regulation).

Substantial equivalence argument

The proposed device employs the same basic operating principles, detector materials (LYSO), scintillator dimensions, and ring diameter as the predicate. Differences in detector ring count and axial FOV do not affect clinical effectiveness or safety—longer FOV reduces scanning time while maintained spatial resolution and image quality specifications demonstrate equivalence. New software features and algorithmic enhancements do not raise new safety or effectiveness concerns based on performance testing and radiologist review.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →